G

Guangdong Biolight Meditech Co Ltd
SZSE:300246

Watchlist Manager
Guangdong Biolight Meditech Co Ltd
SZSE:300246
Watchlist
Price: 14.43 CNY -1.43% Market Closed
Market Cap: ¥3.8B

Wall Street
Price Targets

Price Targets Summary
Guangdong Biolight Meditech Co Ltd

There are no price targets for Guangdong Biolight Meditech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Guangdong Biolight Meditech Co Ltd Competitors:
Price Targets
SK
Sigdo Koppers SA
-5% Downside
PMT
PennyMac Mortgage Investment Trust
2% Upside
CMTG
Claros Mortgage Trust Inc
18% Upside
XO
Exotic Food PCL
87% Upside
PHUN
Phunware Inc
224% Upside

Revenue
Forecast

16% / Year
Past Growth
85% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
16% / Year
Past Growth
85% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 13 years the compound annual growth rate for Guangdong Biolight Meditech Co Ltd's revenue is 16%. The projected CAGR for the next 1 year is 85%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guangdong Biolight Meditech Co Ltd's stock price target?
Not Available

Guangdong Biolight Meditech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Guangdong Biolight Meditech Co Ltd's Revenue forecast?
Projected CAGR
85%

For the last 13 years the compound annual growth rate for Guangdong Biolight Meditech Co Ltd's revenue is 16%. The projected CAGR for the next 1 year is 85%.

Back to Top